Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: A glycolysis-based 4-mRNA signature correlates with the prognosis and cell cycle process in patients with bladder cancer

Fig. 5

An established nomogram for predicting 3- and 5-year OS. a Nomogram incorporated with the 4-mRNA signature and clinical factors for prediction of the 3- and 5-year OS in patients with bladder cancer in the TCGA dataset. b Calibration curve of the nomogram for the prediction of 3- and 5-year OS. c Time‑dependent ROC curves based on the nomogram for 3‑ and 5‑year OS

Back to article page